On ECHEMI
Home > Drugs > Capecitabine Registered Holders
Capecitabine structure

Capecitabine structure

Capecitabine

Colourless solidCapecitabine is a new oral fluoropyrimidine carbamate for patients with advanced neoplastic disease, approved as Xeloda for the treatment of refractory metastatic breast cancer after failure on Paclitaxel and an anthracycline-based chemotherapy regimen ; it is a prodrug of doxifluridine (5-fluorouracil ; 5-FU) activated by a cascade of 3 enzymes concentrated in human liver and cancer tissue, resulting in the selective release of 5-FU at the tumor site and offering a prolo

Find 85 Related Holders

ScinoPharm Taiwan Ltd
United States United States

API Registration Country

API Active
MSN LABORATORIES PRIVATE LIMITED
European Union European Union

API Registration Country

API Active
SHANDONG BOYUAN PHARMACEUTICAL CO., LTD.
European Union European Union

API Registration Country

API Active
SHANDONG ANXIN PHARMACEUTICAL CO., LTD
European Union European Union

API Registration Country

API Active
MAC CHEM PRODUCTS INDIA PVT LTD
United States United States

API Registration Country

API Inactive
APOTEX PHARMACHEM INDIA PVT LTD
United States United States

API Registration Country

API Inactive
QILU TIANHE PHARMACEUTICAL CO LTD
United States United States

API Registration Country

API Inactive
MYLAN LABORATORIES LTD
United States United States

API Registration Country

API Inactive
CADILA HEALTHCARE LTD
United States United States

API Registration Country

API Inactive
SIGNA SA DE CV
United States United States

API Registration Country

API Inactive
Recommended Suppliers of Capecitabine
View 283 Suppliers Request for Quotation
Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.